Hafiz Muhammad Irfan

9PUBLICATIONS
5CO-AUTHORS
Traditional Chinese medicine and treatmentsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsBiologically active moleculesNutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 28, 2025
Therapeutic role of Crateva religiosa in diabetic nephropathy: Insights into key signaling pathways.

|Aug 27, 2024
In vitro and in vivo modulatory effects of fluoxetine on gene expression and antioxidant enzymes in CFA-induced chronic inflammatory model: drug repurposing for arthritis.

Hafiz Muhammad Irfan, Awais Anjum, Mulazim Hussain Asim

|May 27, 2024
Trans-Chalcone (1-3-diphenyl-2-propen-1-one) as a Therapeutic Candidate in Joint Inflammation via Reduction of TNF-α, IL-1β, IL-6, and IL-17 in Rodents: An In Vivo Study by RT-PCR and ELISA analysis.

Zeeshan Jabbar, Hafiz M Irfan, Alamgeer

|Sep 09, 2023
Attenuation of CFA-induced chronic inflammation by a bicyclic monoterpene fenchone targeting inducible nitric oxide, prostaglandins, C-reactive protein and urea.

Shoaib Nawaz, Hafiz Muhammad Irfan, Alamgeer

|Mar 31, 2022
Phytochemicals targeting NAFLD through modulating the dual function of forkhead box O1 (FOXO1) transcription factor signaling pathways.

Usman Sabir, Hafiz Muhammad Irfan, Alamgeer

|Mar 04, 2022
Reduction of Hepatic Steatosis, Oxidative Stress, Inflammation, Ballooning and Insulin Resistance After Therapy with Safranal in NAFLD Animal Model: A New Approach.

Usman Sabir, Hafiz Muhammad Irfan, Alamgeer

Pageof 2

Frequent Collaborators

1 joint publications

Magda H Abdellattif

1 joint publications

Usman Sabir

1 joint publications

Aman Ullah

1 joint publications

Yusuf S Althobaiti